Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pink Kush is a named **cannabis chemovar and cultivar/strain** rather than a single standardized pharmaceutical product. It is generally described as an indica-dominant cultivar related to OG Kush and is used in inhaled or orally ingested cannabis products for non-medical and medical cannabis purposes. Its pharmacology is driven by the **combined cannabinoid and terpene profile of the plant**, typically with delta-9-tetrahydrocannabinol as the dominant psychoactive constituent and relatively low cannabidiol, producing central and peripheral effects primarily through cannabinoid receptor signaling. Because Pink Kush is a cultivar name used across multiple producers and jurisdictions, its exact composition, potency, terpene balance, dosage form, and clinical positioning can vary materially between products, so it should be treated as a **non-specific cannabis strain designation** rather than a uniquely defined drug entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pink Kush.